In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Edema, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Hemic and Lymphatic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, alpha thalassemia spectrum, fetal erythroblastosis, hematologic disorder, hereditary disease, hydrops fetalis, immune system disorder, inherited hemoglobinopathy, pregnancy disorder, thalassemia	Recruiting	Not applicable	2023-04-12		NCT05797272

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese University of Hong Kong	480

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Chinese University of Hong Kong	Shatin	Hong Kong	9